In order to test dynamic changes in anti-NPM1 autoantibodies during malignant transformation from chronic liver diseases to liver cancer, the sera from three HCC cases with serial bleeding serum samples were available in our laboratory, and were tested in the present study. The gene discussed is NPM1; the disease is hepatocellular carcinoma.